Aligos Therapeutics
Clinical trials sponsored by Aligos Therapeutics, explained in plain language.
-
New pill targets hepatitis b virus in early human trial
Disease control CompletedThis early-stage study tested a new oral drug, ALG-000184, to see if it is safe and can reduce the hepatitis B virus in people with a chronic infection. The trial first gave the drug to healthy volunteers to check safety, then gave it to patients with hepatitis B, both alone and …
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 02:05 UTC
-
Scientists test COVID drug safety in people with kidney issues
Knowledge-focused CompletedThis early study tested how a potential COVID-19 drug, ALG-097558, is processed in the body of people with and without severe kidney problems. It involved 12 participants who took the drug orally twice a day. The main goal was to understand if kidney function changes how the drug…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test COVID drug safety in people with liver issues
Knowledge-focused CompletedThis study tested a potential oral medicine for COVID-19, called ALG-097558, to see how it is processed in the body of people with moderate liver problems compared to healthy people. Sixteen participants took the drug twice a day. The main goal was to measure the drug's levels in…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC